Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation

Details for Australian Patent Application No. 2004262901 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Meade, Christopher John Montague; Pieper, Michael P.; Pairet, Michel

Agent Spruson & Ferguson

Pub. Number AU-B-2004262901

PCT Pub. Number WO2005/014005

Priority 03017162.3 29.07.03 EP

Filing date 17 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 13 May 2010

International Classifications

A61K 31/439 (2006.01) - the ring forming part of a bridged ring system, e.g. quinuclidine

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 31/4745 (2006.01)

A61K 31/57 (2006.01) - substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone

A61K 31/573 (2006.01)

A61K 31/575 (2006.01) - substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

A61K 31/58 (2006.01) - containing heterocyclic rings, e.g. aldosterone, danazol, stanozolol, pancuronium, digitogenin

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 11/06 (2006.01) Drugs for disorders of the respiratory system

Event Publications

16 March 2006 PCT application entered the National Phase

  PCT publication WO2005/014005 Priority application(s): WO2005/014005

13 May 2010 Application Accepted

  Published as AU-B-2004262901

9 September 2010 Standard Patent Sealed

9 August 2012 Offer to Surrender

  Boehringer Ingelheim International GmbH Binger Strasse 173 , 55216 Ingelheim , the Patentee of Letters Patent 2004262901 dated 26.08.2010 for an invention titled ' Combination of an anticholinergic and a steroid and its use to treat respiratory disorders by inhalation' offers to surrender the said Letters Patent. Any person desiring to be heard before the said offer to surrender Offer to Surrender is accepted must lodge a request to be heard within one month from the date of this journal.

4 October 2012 Innovation Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262902-Medicaments for inhalation comprising betamimetics and an anticholinergic

2004262897-Combination of mGluR2 antagonist and ache inhibitor for treatment of acute and/or chronic neurological disorders